Cite Filings / LCTX / 0000919574-22-002416
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Lineage Cell Therapeutics, Inc. · Filed 2022-03-25 · Acc 0000919574-22-002416

Documents 1

  • SC 13D/A Beneficial Ownership Report , d9434491_13g-a.htm

Around this filing

  • 2024-02-08 SC 13D/A Beneficial Ownership Report
  • 2022-03-29 4 Director bought 35,000 shares at $1.63 ($57,050)
  • 2022-03-28 4 President and CEO bought 5,250 shares at $1.38 ($7,245)
  • 2022-03-25 4 Director bought 7,000 shares at $1.40 ($9,800)
  • 2022-03-25 4 Director bought 930,106 shares at an average $1.42 ($1,317,667)
  • 2022-03-25 SC 13D/A Beneficial Ownership Report
  • 2021-03-16 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading d9434491_13g-a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…